Search Results Search Sort by RelevanceMost Recent Case and Commentary Mar 2021 印第安人非紧急护理卫生服务转诊能否得到公平分配? Hannah Wenger(医学博士) and Jo Henderson-Frost(医学博士) AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215. Case and Commentary Mar 2021 ¿Se pueden asignar equitativamente las derivaciones para atención no urgente del Servicio de Salud para Indígenas Estadounidenses? Hannah Wenger, MD and Jo Henderson-Frost, MD AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215. Policy Forum Dec 2020 Inconsistency in Brain Death Determination Should Not Be Tolerated Erin Barnes, MD and David Greer, MD, MA Since 1995, the American Academy of Neurology has provided guidelines for brain death determination, but nationwide adherence to these guidelines has been incomplete. AMA J Ethics. 2020;22(12):E1027-1032. doi: 10.1001/amajethics.2020.1027. Policy Forum Dec 2020 What Should We Do About the Mismatch Between Legal Criteria for Death and How Brain Death Is Diagnosed? Nathaniel M. Robbins, MD and James L. Bernat, MD Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements. AMA J Ethics. 2020;22(12):E1038-1046. doi: 10.1001/amajethics.2020.1038. Case and Commentary Mar 2021 Can Indian Health Service Referrals for Nonemergent Care Be Allocated Equitably? Hannah Wenger, MD and Jo Henderson-Frost, MD Injustice is endemic to IHS operations when its stewards are forced to defer payment for patients’ nonemergent care. AMA J Ethics. 2021;23(3):E215-222. doi: 10.1001/amajethics.2021.215. Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557. Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021;23(9):E702-704. doi: 10.1001/amajethics.2021.702. Viewpoint Sep 2021 Is the FDA Failing Women? Madris Kinard, MBA and Rita F. Redberg, MD, MSc Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness. AMA J Ethics. 2021;23(9):E750-756. doi: 10.1001/amajethics.2021.750. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Next page Next › Last page Last »
Case and Commentary Mar 2021 印第安人非紧急护理卫生服务转诊能否得到公平分配? Hannah Wenger(医学博士) and Jo Henderson-Frost(医学博士) AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215.
Case and Commentary Mar 2021 ¿Se pueden asignar equitativamente las derivaciones para atención no urgente del Servicio de Salud para Indígenas Estadounidenses? Hannah Wenger, MD and Jo Henderson-Frost, MD AMA J Ethics. 2021;E215-222. doi: 10.1001/amajethics.2021.215.
Policy Forum Dec 2020 Inconsistency in Brain Death Determination Should Not Be Tolerated Erin Barnes, MD and David Greer, MD, MA Since 1995, the American Academy of Neurology has provided guidelines for brain death determination, but nationwide adherence to these guidelines has been incomplete. AMA J Ethics. 2020;22(12):E1027-1032. doi: 10.1001/amajethics.2020.1027.
Policy Forum Dec 2020 What Should We Do About the Mismatch Between Legal Criteria for Death and How Brain Death Is Diagnosed? Nathaniel M. Robbins, MD and James L. Bernat, MD Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements. AMA J Ethics. 2020;22(12):E1038-1046. doi: 10.1001/amajethics.2020.1038.
Case and Commentary Mar 2021 Can Indian Health Service Referrals for Nonemergent Care Be Allocated Equitably? Hannah Wenger, MD and Jo Henderson-Frost, MD Injustice is endemic to IHS operations when its stewards are forced to defer payment for patients’ nonemergent care. AMA J Ethics. 2021;23(3):E215-222. doi: 10.1001/amajethics.2021.215.
Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.
AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021;23(9):E702-704. doi: 10.1001/amajethics.2021.702.
Viewpoint Sep 2021 Is the FDA Failing Women? Madris Kinard, MBA and Rita F. Redberg, MD, MSc Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness. AMA J Ethics. 2021;23(9):E750-756. doi: 10.1001/amajethics.2021.750.